---
title: 'CML: Is it possible to stop taking tablets?'
hide_page_title: false
show_sidebar: false
hide_git_sync_repo_link: false
---

ğŸ’Š Short answer: Yes, it is possible â€” but not quickly, not simply, not for everyone, and not always.

â˜ï¸â— Stopping treatment should only be done in centers where high-quality, highly sensitive molecular monitoring is available!

ğŸ›‘ After discontinuation, about 50% of patients lose their achieved molecular response, but restarting therapy usually restores it in most cases.

â­• Fluctuations between MMR, MR4, MR4.5, and MR5 are not considered loss of response.

â­• About 80% of molecular relapses occur within 6â€“8 months after stopping therapy.

âœ… Requirements (most important and optimal) for stopping TKI therapy

âš ï¸ Mandatory:
ğŸŸ¢ CML must be in the chronic phase (no history of acceleration or blast crisis).
ğŸŸ¢ Molecular monitoring by real-time PCR must be available, with results expressed on the International Scale (IS).
ğŸŸ¢ Possibility of molecular monitoring at least once a month during the first 6 months, every 2 months for the next 6â€“12 months, and then every 3 months thereafter.

âš ï¸ Optimal:
ğŸŸ¢ TKI treatment duration more than 5 years.
ğŸŸ¢ Duration of deep molecular response more than 3 years for MR4, or more than 2 years for MR4.5.

ğŸ™ Do not stop treatment on your own, even if you have been in a deep molecular response for a long time.